Pharma Stories, Blogs, Interviews & Press Releases
Biosimilar Partnering in 2026: Finished Product, Ready-to-Fill DS, Cell Line Transfer and CDMO
By the PharmaTradz BD Team. Published November 2026. A few years ago, entering the biosimilar market meant one thing: sp...
Read Full Story
Plasma-Derived Medicines: How to Source Immunoglobulin, Albumin and Clotting Factors
By the PharmaTradz BD Team. Published November 2026. Plasma-derived medicines are unlike any other product a pharmaceuti...
Read Full Story
Cell and Gene Therapy Access: Routes for Hospitals and Health Systems Outside the US and EU
By the PharmaTradz BD Team. Published November 2026. Cell and gene therapies have changed what is possible for some bloo...
Read Full Story
Shortage Import Routes: Section 19A and Its Equivalents Worldwide
By the PharmaTradz BD Team. Published November 2026. When a registered medicine runs short, patients do not stop needing...
Read Full Story
EU-CTD Dossier Licensing: The Fastest Route Into ROW Markets
By the PharmaTradz BD Team. Published November 2026. Ask a distributor in the Gulf, Latin America, Southeast Asia or Afr...
Read Full Story
Critical Raw Materials: Securing API and Starting Material Supply in 2026
By the PharmaTradz BD Team. Published November 2026. A finished medicine is only as secure as the least visible chemical...
Read Full Story
Reference Product Sourcing: Buying RLDs and Comparators for Bioequivalence Studies
By the PharmaTradz BD Team. Published November 2026. Every generic medicine starts with a purchase that has nothing gene...
Read Full Story
Special Import and Emergency Tenders: How Suppliers Can Bid Without a Local Registration
By the PharmaTradz BD Team. Published November 2026. Most pharmaceutical tenders have one condition that rules out the m...
Read Full Story
Reserve Antibiotics: How Hospitals and Distributors Can Source Last-Line Treatments
By the PharmaTradz BD Team. Published November 2026. When a patient has an infection caused by bacteria resistant to car...
Read Full Story
US Drug Discontinuations: What the FDA List Means for Manufacturers and Exporters
By the PharmaTradz BD Team. Published November 2026. Most attention goes to the US drug shortage list. The FDA's list of...
Read Full Story
WHO Opens Prequalification for Childhood Cancer and Opioid Medicines: What Manufacturers Should Know
By the PharmaTradz BD Team. Published October 2026. In the space of four months, WHO has opened its prequalification pro...
Read Full Story
The EU Pharma Package and Generic Launches: What Changes for Generic and Biosimilar Companies
By the PharmaTradz BD Team. Published October 2026. Europe's medicines law is about to change for the first time in more...
Read Full Story